BANK OF AMERICA CORP /DE/ - NEWLINK GENETICS CORP ownership

NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 72 filers reported holding NEWLINK GENETICS CORP in Q3 2013. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of NEWLINK GENETICS CORP
ValueSharesWeighting
Q4 2019$186,000
+59.0%
73,488
-0.4%
0.00%
Q3 2019$117,000
-20.4%
73,805
-25.6%
0.00%
Q2 2019$147,000
-62.0%
99,154
-50.6%
0.00%
Q1 2019$387,000
+182.5%
200,765
+122.9%
0.00%
Q4 2018$137,000
-41.2%
90,070
-7.9%
0.00%
Q3 2018$233,000
-75.9%
97,766
-51.9%
0.00%
Q2 2018$967,000
-55.4%
203,179
-32.0%
0.00%
Q1 2018$2,166,000
+97.8%
298,672
+121.3%
0.00%
Q4 2017$1,095,000
+0.6%
134,990
+26.4%
0.00%
Q3 2017$1,088,000
+2372.7%
106,832
+1652.5%
0.00%
Q2 2017$44,000
-94.3%
6,096
-80.9%
0.00%
Q1 2017$769,000
+983.1%
31,911
+361.8%
0.00%
Q4 2016$71,000
+97.2%
6,910
+190.7%
0.00%
Q3 2016$36,000
-74.3%
2,377
-80.9%
0.00%
Q2 2016$140,000
+211.1%
12,446
+411.3%
0.00%
Q1 2016$45,000
-87.3%
2,434
-75.0%
0.00%
Q4 2015$355,000
+454.7%
9,755
+444.4%
0.00%
Q3 2015$64,000
-92.2%
1,792
-90.4%
0.00%
Q2 2015$823,000
-87.7%
18,606
-84.8%
0.00%
-100.0%
Q1 2015$6,677,000
+1724.3%
122,033
+1226.3%
0.00%
Q4 2014$366,000
+242.1%
9,201
+84.2%
0.00%
Q3 2014$107,000
-46.2%
4,996
-33.2%
0.00%
Q2 2014$199,000
-44.4%
7,478
-40.6%
0.00%
Q1 2014$358,000
+163.2%
12,591
+104.1%
0.00%
Q4 2013$136,000
+580.0%
6,169
+473.3%
0.00%
Q3 2013$20,000
-96.2%
1,076
-96.0%
0.00%
Q2 2013$528,00026,8190.00%
Other shareholders
NEWLINK GENETICS CORP shareholders Q3 2013
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 93,533$962,0001.69%
WALL STREET ASSOCIATES 108,900$1,119,0000.74%
NORTHWEST WEALTH MANAGEMENT, LLC 57,482$591,0000.60%
Orbimed Advisors 1,991,700$20,475,0000.26%
TFS CAPITAL LLC 92,041$946,0000.25%
Intrinsic Edge Capital Management LLC 40,000$411,0000.18%
SECOR Capital Advisors, LP 100,529$1,033,0000.13%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 176,077$1,810,0000.12%
Piermont Capital Management Inc. 41,400$426,0000.10%
Vident Investment Advisory, LLC 67,209$691,0000.08%
View complete list of NEWLINK GENETICS CORP shareholders